Jonathan Hurov

Jonathan Hurov is an experienced executive in the field of biology, currently serving as the Executive Vice President of Discovery Biology and previously as Senior Vice President of Biology at FogPharma since December 2020. Prior roles include Vice President of Discovery Biology and Platforms at Cygnal Therapeutics and various positions at Agios Pharmaceuticals, where responsibilities extended from Director to Senior Scientist. Earlier in their career, Jonathan worked as a Senior Research Scientist at Wyeth Pharmaceuticals and held a Postdoctoral Research Fellow position at Harvard Medical School. Educational credentials include a Postdoctoral Fellowship from Harvard Medical School, a PhD in Molecular and Cellular Biology from Washington University School of Medicine in St. Louis, and a B.Sc. in Biochemistry from the University of Victoria.